Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography | Translational Psychiatry
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
PDF) Major Depressive Disorder and Kappa Opioid Receptor Antagonists
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Some Actions of Arylacetamides in the Heart and Cardiovascular System | Download Table
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Major Depressive Disorder and Kappa Opioid Receptor
PDF) Targeting opioid receptor signalling in depression: do we need selective kappa opioid receptor antagonists?
Pharmacology of Opioids: What Practitioners Need to Know
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
